MedPath

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

Not Applicable
Recruiting
Conditions
Analgesia
Registration Number
NCT05361837
Lead Sponsor
National Cancer Institute, Egypt
Brief Summary

This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
172
Inclusion Criteria
  • patients scheduled for modified radical mastectomy,
  • Age 18-65 years,
  • ASA I-II
Exclusion Criteria
  • patient refusal,
  • coagulation defects,
  • abnormal kidney or liver functions,
  • local infection at site of injection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
First time to receive analgesiaFirst 24 hours postoperatively

first time to receive morphine analgesia in hours

Total analgesic requisiteFirst 24 hours postoperatively

total amount of morphine consumption in the first 24 hours postoperatively in mg

Secondary Outcome Measures
NameTimeMethod
Pain scoresFirst 24 hours postoperatively

pain scores will be assessed using Visual Analogue Scale on a sale from 0 to 10 with 0 meanung no pain and 10 meaning severe pain

Side effectsFirst 24 hours postoperatively

nausea and vomiting and hematoma at site of injection

Perioperative heart rate valuesFirst 24 hours

heart rate values in the form of beat per minute in the perioperative period including preoperative, intraoperative and postoperative

Mean arterial blood pressureFirst 24 hours

Mean arterial blood pressure values in the form mmHg in the perioperative period including preoperative, intraoperative and postoperative

Trial Locations

Locations (1)

Walaa Y Elsabeeny

🇪🇬

Cairo, Egypt

Walaa Y Elsabeeny
🇪🇬Cairo, Egypt
Walaa Y Elsabeeny, MD
Contact
+201007798466
walaa.elsabeeny@nci.cu.edu.eg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.